Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
One World Products, Inc. (OWPC)
USD0.01
0.00 (-7.36%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address
3471 West Oquendo Road 89118
Las Vegas, NV, US
Las Vegas, NV, US
CEO
Isiah L. Thomas
Website
oneworldproducts.com
IPO
2018-11-15
CIK 1622244 ISIN US68248W1080
Description
One World Products, Inc. (OWPC) operates as an international producer and supplier of unrefined cannabis and hemp commodities. The company's operations encompass the cultivation, processing, and distribution of various cannabis derivatives, including crude cannabis oil, purified distillates, and isolates. Previously known as One World Pharma, Inc., the organization rebranded as One World Products, Inc. in November 2021. Its corporate headquarters are located in Las Vegas, Nevada.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.01
0.00 (-7.36%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
759.2K
Beta
-0.65
Float Shares
60.03M
Free Float %
50.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -21.59% | -9.83% | -3.39% | -54.92% | -67.60% | -79.11% | -75.41% | -92.27% | -96.75% | -99.73% | -99.73% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.01
Quality scores
Altman Z-Score
-3.77
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%-35.9% Q3'25: +3,193.7% (vs Q3'24)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+31.7% ★ Q3'25: +769.7% (vs Q3'24)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%-58,267.8% Q3'25: +333.6% (vs Q3'24)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%-35,204.5% Q3'25: +11,055.3% (vs Q3'24)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%— Q3'25: +371.2% (vs Q3'24)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+45.9% Q3'25: +4.5% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×-2.24× Q3'25: 0.29× (vs Q3'24)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 1/5 | 5/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
662.0K
OE per share TTM
0.01
Owner's Yield
105.16%
Maintenance CapEx ratio
19.09%
Maint CapEx / Avg PPE
2,075.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
3
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | L. Thomas III | 23.75M | 28.00% | 3.75M | 20.00M | 3.75M | 20.00M | IN | USA | 2021-06-30 | ↗ |
| 2 | International, LLC | 20.00M | 24.60% | — | 20.00M | — | 20.00M | PN | Illinois | 2021-06-30 | ↗ |
| 3 | Craig Ellins | 3.97M | 6.40% | 3.97M | — | 3.97M | — | IN | United States | 2021-09-30 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
694.4K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+694,445
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | Peterson Todd A | Officer | A-Award | A | Common Stock | 694,445 | 0.02 | 15.0K | 2,703,535 | D | ↗ |
| 2024-12-25 | Peterson Todd A | Officer | A-Award | A | Common Stock | 909,090 | 0.02 | 15.0K | 2,009,090 | D | ↗ |
| 2024-11-08 | Thomas Isiah III | Director / Officer | A-Award | A | Series C Special Preferred Stock | 100 | 486,512.00 | 48.65M | 100 | D | ↗ |
| 2024-09-25 | Peterson Todd A | Officer | A-Award | A | Common Stock | 600,000 | 0.03 | 15.0K | 1,100,000 | D | ↗ |
| 2024-07-25 | Perego Kenneth II | Director | A-Award | A | Series A Preferred Stock | 15,000 | 0.00 | — | 2,600,000 | — | ↗ |
| 2024-07-01 | Peterson Todd A | Officer | — | D | Common Stock | 0 | 0.00 | — | 625,000 | — | ↗ |
| 2024-03-28 | Sommer Joerg Herman Walter | Officer | A-Award | A | Common Stock | 250,000 | 0.00 | — | 2,381,000 | — | ↗ |
| 2024-03-15 | Thomas Isiah III | Director / Officer | A-Award | A | Common Stock | 138,000 | 0.00 | — | 2,638,000 | — | ↗ |
| 2024-03-15 | Sommer Joerg Herman Walter | Officer | A-Award | A | Common Stock | 500,000 | 0.00 | — | 2,000,000 | — | ↗ |
| 2024-03-15 | Perego Kenneth II | Director | A-Award | A | Common Stock | 2,000,000 | 0.00 | — | 11,100,000 | — | ↗ |
| 2024-03-15 | McCabe John S | 10% Owner | A-Award | A | Common Stock | 9,017,000 | 0.00 | — | 22,117,180 | — | ↗ |
| 2024-03-15 | Buffalo Terry Lynn | Director | A-Award | A | Common Stock | 2,000,000 | 0.00 | — | 2,000,000 | — | ↗ |
| 2023-12-22 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 250,000 | 0.04 | 9.1K | 13,100,180 | — | ↗ |
| 2023-12-15 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 300,000 | 0.05 | 15.3K | 12,850,180 | — | ↗ |
| 2023-11-06 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 22,999 | 0.05 | 1.2K | 12,550,180 | — | ↗ |
| 2023-11-01 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 71,000 | 0.05 | 3.3K | 12,527,181 | — | ↗ |
| 2023-10-30 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.05 | 4.8K | 12,456,181 | — | ↗ |
| 2023-10-26 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.06 | 5.8K | 12,356,181 | — | ↗ |
| 2023-10-23 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.06 | 6.1K | 12,256,181 | — | ↗ |
| 2023-10-11 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.08 | 7.8K | 12,156,181 | — | ↗ |
| 2023-10-10 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 24,300 | 0.08 | 1.9K | 12,056,181 | — | ↗ |
| 2023-10-09 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 31,000 | 0.08 | 2.4K | 12,031,881 | — | ↗ |
| 2023-10-06 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 200,000 | 0.08 | 16.0K | 12,000,881 | — | ↗ |
| 2023-09-28 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 88,000 | 0.10 | 8.4K | 11,800,881 | — | ↗ |
| 2023-07-07 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 104,500 | 0.08 | 8.4K | 11,712,881 | — | ↗ |
| 2023-06-23 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 110,000 | 0.08 | 8.7K | 11,608,381 | — | ↗ |
| 2023-06-15 | Sommer Joerg Herman Walter | Officer | A-Award | A | Common Stock | 1,500,000 | 0.00 | — | 1,550,000 | — | ↗ |
| 2023-05-23 | Sommer Joerg Herman Walter | Officer | — | D | Common Stock | 0 | 0.00 | — | 50,000 | — | ↗ |
| 2023-03-14 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 195,500 | 0.06 | 11.7K | 11,498,381 | — | ↗ |
| 2023-03-06 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.07 | 7.3K | 11,302,881 | — | ↗ |
| 2023-02-15 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 200,000 | 0.06 | 12.8K | 11,202,881 | — | ↗ |
| 2023-02-14 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 3,000,000 | 0.10 | 300.0K | 11,002,881 | — | ↗ |
| 2023-02-09 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 150,000 | 0.07 | 10.1K | 7,802,881 | — | ↗ |
| 2023-02-08 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.07 | 6.8K | 7,652,881 | — | ↗ |
| 2023-02-07 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 200,000 | 0.07 | 14.7K | 7,552,881 | — | ↗ |
| 2023-02-06 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 96,609 | 0.08 | 7.7K | 7,352,881 | — | ↗ |
| 2023-02-01 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 87,719 | 0.08 | 7.0K | 7,256,272 | — | ↗ |
| 2023-01-31 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 40,000 | 0.08 | 3.2K | 7,168,553 | — | ↗ |
| 2023-01-30 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 115,000 | 0.08 | 9.2K | 7,128,553 | — | ↗ |
| 2023-01-25 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 24,500 | 0.08 | 1.8K | 7,013,553 | — | ↗ |
| 2023-01-24 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.08 | 8.0K | 6,989,053 | — | ↗ |
| 2023-01-20 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 20,000 | 0.08 | 1.7K | 6,889,053 | — | ↗ |
| 2023-01-12 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 195,111 | 0.08 | 15.6K | 6,869,053 | — | ↗ |
| 2023-01-11 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 21,000 | 0.07 | 1.6K | 6,673,942 | — | ↗ |
| 2023-01-05 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 200,000 | 0.07 | 14.0K | 6,652,942 | — | ↗ |
| 2022-12-20 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 37,000 | 0.08 | 2.9K | 6,452,942 | — | ↗ |
| 2022-10-27 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 400,000 | 0.08 | 33.0K | 6,415,942 | — | ↗ |
| 2022-10-26 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 200,000 | 0.09 | 18.0K | 6,015,942 | — | ↗ |
| 2022-09-21 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 1,010 | 0.09 | 90.90 | 5,815,942 | — | ↗ |
| 2022-09-19 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 5,600 | 0.09 | 498.40 | 5,814,932 | — | ↗ |
| 2022-09-15 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 200,000 | 0.10 | 20.0K | 5,809,332 | — | ↗ |
| 2022-09-13 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 60,000 | 0.10 | 6.0K | 5,609,332 | — | ↗ |
| 2022-09-01 | Buffalo Terry Lynn | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-08-09 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 40,450 | 0.10 | 4.0K | 5,549,332 | — | ↗ |
| 2022-08-04 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 50,000 | 0.11 | 5.3K | 5,508,882 | — | ↗ |
| 2022-08-01 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 81,500 | 0.12 | 9.6K | 5,458,882 | — | ↗ |
| 2022-07-29 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 92,350 | 0.12 | 11.1K | 5,377,382 | — | ↗ |
| 2022-06-17 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 40,000 | 0.11 | 4.2K | 5,285,032 | — | ↗ |
| 2022-06-16 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 18,717 | 0.10 | 1.9K | 5,245,032 | — | ↗ |
| 2022-06-09 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.11 | 10.8K | 5,226,315 | — | ↗ |
| 2022-06-08 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.10 | 10.1K | 5,126,315 | — | ↗ |
| 2022-06-07 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 150,000 | 0.10 | 15.2K | 5,026,315 | — | ↗ |
| 2022-06-06 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 181,000 | 0.11 | 19.2K | 4,876,315 | — | ↗ |
| 2022-06-03 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 193,480 | 0.09 | 17.4K | 4,695,315 | — | ↗ |
| 2022-05-09 | McCabe John S | 10% Owner | P-Purchase | A | Common Stock | 50,000 | 0.08 | 4.0K | 4,501,835 | — | ↗ |
| 2022-05-03 | McCabe John S | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 4,451,835 | — | ↗ |
| 2022-02-14 | Woods Timothy | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-12-31 | Gabriel Vahe | Officer | A-Award | A | Common Stock | 673,582 | 0.00 | — | 673,582 | — | ↗ |
| 2021-07-12 | Thomas Isiah III | Director / Officer / 10% Owner | A-Award | A | Series B Preferred Stock | 33,333 | 0.15 | 5.0K | 200,000 | — | ↗ |
| 2021-06-14 | Thomas Isiah III | Director / Officer / 10% Owner | A-Award | A | Series B Preferred Stock | 33,333 | 0.15 | 5.0K | 166,667 | — | ↗ |
| 2021-05-28 | Gabriel Vahe | Officer | A-Award | A | Stock Option (Right to buy) | 1,000,000 | 0.17 | 172.8K | 1,000,000 | — | ↗ |
| 2021-05-17 | Thomas Isiah III | Director / Officer / 10% Owner | A-Award | A | Series B Preferred Stock | 33,334 | 0.15 | 5.0K | 133,334 | — | ↗ |
| 2021-04-19 | Thomas Isiah III | Director / Officer / 10% Owner | A-Award | A | Series B Preferred Stock | 16,667 | 0.15 | 2.5K | 100,000 | — | ↗ |
| 2021-04-05 | Thomas Isiah III | Officer | A-Award | A | Series B Preferred Stock | 16,666 | 0.15 | 2.5K | 83,333 | — | ↗ |
| 2021-03-22 | Thomas Isiah III | Director / Officer / 10% Owner | A-Award | A | Series B Preferred Stock | 16,667 | 0.15 | 2.5K | 66,667 | — | ↗ |
| 2021-03-15 | McCabe John S | 10% Owner | — | D | Series B Preferred Stock | 2,000,000 | 0.00 | — | 0 | — | ↗ |
| 2021-03-08 | Thomas Isiah III | Director / Officer / 10% Owner | A-Award | A | Series B Preferred Stock | 16,667 | 0.15 | 2.5K | 50,000 | — | ↗ |
| 2021-02-22 | Thomas Isiah III | Director / Officer / 10% Owner | A-Award | A | Series B Preferred Stock | 16,667 | 0.15 | 2.5K | 33,333 | — | ↗ |
| 2021-02-07 | Thomas Isiah III | Director / Officer | A-Award | A | Series B Preferred Stock | 16,666 | 0.15 | 2.5K | 16,666 | — | ↗ |
| 2021-01-01 | Thomas Isiah III | Director / Officer | A-Award | A | Stock Option (Right to buy) | 5,500,000 | 0.13 | 715.0K | 5,500,000 | — | ↗ |
| 2021-01-01 | RABEN BRUCE I | Director / Officer | A-Award | A | Stock Option (Right to buy) | 475,000 | 0.13 | 61.8K | 475,000 | — | ↗ |
| 2021-01-01 | Perego Kenneth II | Director | — | D | Options to purchase Common Stock | 350,000 | 0.13 | 45.5K | 0 | — | ↗ |
| 2020-12-31 | Thomas Isiah III | Director / Officer | D-Return | D | Stock Option (Right to buy) | 5,500,000 | 0.55 | 3.03M | 0 | — | ↗ |
| 2020-12-31 | RABEN BRUCE I | Director / Officer | D-Return | D | Stock Option (Right to Buy) | 125,000 | 0.50 | 62.5K | 0 | — | ↗ |
| 2020-12-31 | Peterson Todd A | Officer | D-Return | D | Stock Option (Right to buy) | 125,000 | 0.13 | 16.3K | 0 | D | ↗ |
| 2020-07-10 | Perego Kenneth II | Director | — | D | Warrants to purchase Common Stock | 550,000 | 0.25 | 137.5K | 0 | — | ↗ |
| 2020-06-03 | Thomas Isiah III | Director / Officer | A-Award | A | Stock Option (Right to buy) | 5,500,000 | 0.55 | 3.03M | 5,500,000 | — | ↗ |
| 2020-05-31 | RABEN BRUCE I | Director | A-Award | A | Stock Option (Right to buy) | 350,000 | 0.56 | 196.0K | 350,000 | — | ↗ |
| 2020-04-23 | McCabe John S | 10% Owner | — | D | Warrants to purchase Common Stock | 150,000 | 0.25 | 37.5K | 0 | — | ↗ |
| 2020-03-03 | RABEN BRUCE I | Director | — | D | Common Stock | 0 | 0.00 | — | 125,000 | — | ↗ |
| 2020-03-03 | Ellins Craig | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 3,745,000 | — | ↗ |
| 2019-02-21 | Perego Kenneth II | Director | — | I | Common Stock | 0 | 0.00 | — | 7,000,000 | — | ↗ |
| 2019-02-08 | RABEN BRUCE I | Director | — | D | Stock Option (Right to Buy) | 125,000 | 0.50 | 62.5K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-1.7K
Shares Outstanding
120.11M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Isiah L. Thomas | Executive Chairman of the Board, CFO & CEO | 120.0K | male |
| Filmoore Walker | Chief Operating Officer | — | male |
| Fukuji Saotome | President of Eco Bio Plastics Midland | — | — |
| William Rowland | Chief Financial Officer & Director | — | male |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for OWPC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
